Treatment of non alcoholic steatotic hepatitis (NASH)

Details for Australian Patent Application No. 2005253897 (hide)

Owner Amsterdam Molecular Therapeutics (AMT) IP B.V.

Inventors Van Deventer, Sander Jan Hendrik

Agent Shelston IP

Pub. Number AU-B-2005253897

PCT Pub. Number WO2005/123117

Priority 60/580,903 21.06.04 US

Filing date 20 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 1 September 2011

International Classifications

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/864 (2006.01) Mutation or genetic engineering - Parvoviral vectors

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123117 Priority application(s): WO2005/123117

14 July 2011 Assignment before Grant

  Amsterdam Molecular Therapeutics B.V.; Academisch Ziekenhuis Bij De Universiteit Van Amsterdam The application has been assigned to Amsterdam Molecular Therapeutics (AMT) IP B.V.

1 September 2011 Application Accepted

  Published as AU-B-2005253897

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005253898-Improvement of barrier integrity in hiv patients with fatty acids

2005253895-Dehydration method